Cart
sales@molnova.com
ML-241
CAS No. 1346528-06-0
ML-241( ML 241 | ML241 )
Catalog No. M11397 CAS No. 1346528-06-0
ML241 is a potent, selective and reversible AAA ATPase p97 inhibitor (IC50=100 nM).
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 70 | In Stock |
|
| 10MG | 113 | In Stock |
|
| 25MG | 249 | In Stock |
|
| 50MG | 421 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameML-241
-
NoteResearch use only, not for human use.
-
Brief DescriptionML241 is a potent, selective and reversible AAA ATPase p97 inhibitor (IC50=100 nM).
-
DescriptionML241 is a potent, selective and reversible AAA ATPase p97 inhibitor (IC50=100 nM); blocks degradation of p97-dependent proteasome substrate with an IC50 of 3.5 uM; induces caspases 3 and 7 and potently blocks proliferation in HCT15 and SW403 cells.
-
In Vitro——
-
In Vivo——
-
SynonymsML 241 | ML241
-
PathwayProteasome/Ubiquitin
-
Targetp97
-
Recptorp97
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1346528-06-0
-
Formula Weight372.46
-
Molecular FormulaC23H24N4O
-
Purity>98% (HPLC)
-
Solubility10 mM in DMSO
-
SMILESC1CCC2=C(C1)C(=NC(=N2)N3CCOC4=CC=CC=C43)NCC5=CC=CC=C5
-
Chemical NameN-benzyl-2-(2,3-dihydro-1,4-benzoxazin-4-yl)-5,6,7,8-tetrahydroquinazolin-4-amine
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Chou TF, et al. Probe Reports from the NIH Molecular Libraries Program [Internet].
2. Chou TF, et al. ChemMedChem. 2013 Feb;8(2):297-312.
3. Fang CJ, et al. ChemMedChem. 2015 Jan;10(1):52-6.
molnova catalog
related products
-
MSC 1094308
MSC1094308 (MSC 1094308) is a reversible, allosteric inhibitor of the type II AAA ATPase human ubiquitin-directed unfoldase (VCP)/p97 and the type I AAA ATPase VPS4B with IC50 of 7.2 and 0.71 uM, respectively.
-
TPX-0046
TPX-0046 is a RET inhibitor designed to overcome resistance to Selpercatinib and Pralsetinib.
-
LC-1028
LC-1028 (LC1028) is a novel potent selective, covalent and irreversible inhibitor of p97 (valosin-containing protein).
